Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases

INTRODUCTION: Ranitidine, a histamine H(2)-receptor antagonist (H(2)RA), is indicated in the management of gastric acid-related disorders. In 2020, the European Medicines Agency (EMA) recommended suspension of all ranitidine-containing medicines in the European Union (EU) due to the presence of N-ni...

Descripción completa

Detalles Bibliográficos
Autores principales: Arinze, Johnmary T., de Ridder, Maria A. J., Vojinovic, Dina, van Ballegooijen, Hanne, Markov, Emanuil, Duarte-Salles, Talita, Rijnbeek, Peter, Verhamme, Katia M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684403/
https://www.ncbi.nlm.nih.gov/pubmed/37907775
http://dx.doi.org/10.1007/s40264-023-01354-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684403/
https://www.ncbi.nlm.nih.gov/pubmed/37907775
http://dx.doi.org/10.1007/s40264-023-01354-9

Ejemplares similares